Medpace Holdings (MEDP) Net Margin (2015 - 2026)

Medpace Holdings has reported Net Margin for 12 years, with the latest figure at 17.53% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin fell 299.0% year-over-year to 17.53%; the trailing twelve-month figure through Mar 2026 stood at 17.19% (down 212.0% YoY), and the FY2025 full-year result was 17.83%, down 134.0% from the prior year.
• Net Margin for Q1 2026 stood at 17.53%, down from 19.07% in the prior quarter.
• The five-year high for Net Margin was 21.81% in Q4 2024, with the low at 13.25% in Q2 2023.
• Historically, Net Margin has averaged 17.23% across 5 years, with a median of 17.21% in 2022.
• Annual changes were most pronounced in 2024 — Net Margin surged 610 bps — and 2026, when it sank 299 bps.
• Medpace Holdings' Net Margin stood at 17.42% in 2022, then fell by 10 bps to 15.71% in 2023, then soared by 39 bps to 21.81% in 2024, then retreated by 13 bps to 19.07% in 2025, then slipped by 8 bps to 17.53% in 2026.
• The last three Net Margin figures came in at 17.53% (Q1 2026), 19.07% (Q4 2025), and 16.84% (Q3 2025), per Business Quant data.